Recently large and exciting decisions have been made at ContextVision. From now on, [they] will focus our pathology business entirely on the establishment of an AI based pathology lab service, and are now in the process of moving the...

In the Pan-European multicenter clinical study FirstPath, INIFY Prostate produced highly accurate, robust and homogenous results at all sites. STOCKHOLM – August 31, 2021 – ContextVision, a medical technology software company specializing...

STOCKHOLM – July 6, 2021 – ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today announced that agreements to conduct a multicenter...

STOCKHOLM – February 11, 2021 – ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today announced that an agreement to conduct clinical...

The platform facilitates a worst-case-first reviewing process, which improves workflow management for pathologists and ensures that critical patients are prioritized Based on its recent analysis of the European prostate cancer screening...

After over 8 years as the CEO at ContextVision, Anita Tollstadius has informed the Board of Directors that she wishes to retire during 2019, to spend more time with her family. "We want to thank Anita for her hard work and contribution to the...